Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor buparlisib (BKM120) in recurrent glioblastoma Meeting Abstract
| Authors: | Wen, P. Y.; Yung, W. K. A.; Mellinghoff, I. K.; Ramkissoon, S.; Alexander, B. M.; Rinne, M. L.; Colman, H.; Omura, A. M. P.; Deangelis, L. M.; Gilbert, M. R.; De Groot, J. F.; Cloughesy, T. F.; Chi, A. S.; Lee, E. Q.; Nayak, L.; Batchelor, T.; Chang, S. M.; Prados, M.; Reardon, D. A.; Ligon, K. L. |
| Abstract Title: | Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor buparlisib (BKM120) in recurrent glioblastoma |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202685 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2019 |
| Notes: | Meeting Abstract: 2019 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
269Mellinghoff -
576De Angelis
Related MSK Work